Shares of Akso Health Group Sponsored ADR (NASDAQ:AHG – Get Free Report) gapped up before the market opened on Monday . The stock had previously closed at $1.52, but opened at $1.66. Akso Health Group shares last traded at $1.51, with a volume of 5,288 shares.
Analysts Set New Price Targets
A number of equities research analysts have recently issued reports on AHG shares. Weiss Ratings restated a “sell (d-)” rating on shares of Akso Health Group in a research note on Monday, April 20th. Wall Street Zen upgraded Akso Health Group to a “sell” rating in a research note on Saturday, May 2nd. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Akso Health Group currently has an average rating of “Sell”.
View Our Latest Stock Analysis on Akso Health Group
Akso Health Group Stock Up 3.2%
Institutional Investors Weigh In On Akso Health Group
A hedge fund recently bought a new stake in Akso Health Group stock. SmartHarvest Portfolios LLC acquired a new position in Akso Health Group Sponsored ADR (NASDAQ:AHG – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 16,748 shares of the company’s stock, valued at approximately $27,000. Institutional investors and hedge funds own 1.21% of the company’s stock.
Akso Health Group Company Profile
Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc and changed its name to Akso Health Group in December 2021.
Read More
- Five stocks we like better than Akso Health Group
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
Receive News & Ratings for Akso Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akso Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
